AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|
13.2 C
New York
Friday, October 23, 2026

Tag: track

newsFORsourcecompanycontentinformation1releasesmarket

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University...

TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3...

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages iRobot Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRBT

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and March 11, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 5, 2025.

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

PhenQ – Round the Clock Weightloss: 2025’s Strongest 24/7 Fat-Burning System for Appetite Control, Sleep-Supported Metabolism & Craving Relief

2025’s Strongest 24/7 Fat-Burning System for Appetite Control, Sleep-Supported Metabolism & Craving Relief 
2025’s Strongest 24/7 Fat-Burning System for Appetite Control, Sleep-Supported Metabolism & Craving Relief

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK, July 16, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /CNW/ -- As lawmakers weigh potential cuts to scientific research...

ARIS MINING, COLOMBIA’S MINISTRY OF ENERGY AND MINES, AND COMMUNITY PARTNERS LAUNCH FORMALIZATION STRATEGY FOR ACTIVE ASM AREAS NEAR MARMATO

Spanish version attached VANCOUVER, BC, July 16, 2025 /CNW/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) announces the signing of...

ARIS MINING, COLOMBIA’S MINISTRY OF ENERGY AND MINES, AND COMMUNITY PARTNERS LAUNCH FORMALIZATION STRATEGY FOR ACTIVE ASM AREAS NEAR MARMATO

Spanish version attached VANCOUVER, BC, July 16, 2025 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) announces the signing of...

NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants.

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abello (Sublingual...

Audien Hearing Adds Chairman, Advisory Board, and Executive Team to Power Next Phase of Growth; Launches Audien Cares Initiative

No.-1 selling OTC hearing aid brand makes strategic moves to meet rising demand and increase impact SCOTTSDALE, Ariz., July 16, 2025 /PRNewswire/ -- Audien Hearing, the world's...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTrack

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers